Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
申请人:Bristol-Myers Squibb Company
公开号:US07960569B2
公开(公告)日:2011-06-14
The present invention provides indole compounds of Formula (I) or (II):
or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables ring A, X1, X2, X3, X4, R6, and R15 are as defined herein. These compounds are selective inhibitors of the human P2Y1 receptor which can be used as medicaments.
本发明提供以下式子(I)或(II)的吲哚化合物:
其中,环A、X1、X2、X3、X4、R6和R15的变量如本文所定义,或其立体异构体、互变异构体、药学上可接受的盐或溶剂形式。这些化合物是选择性抑制人类P2Y1受体的药物。